Home » FTC Approves Novartis-GSK Deal; Former Asked to Divest Nicotine Patch Business
The Federal Trade Commission has finally approved the joint venture of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline Plc (ADR) (NYSE:GSK) in consumer health products, and Novartis has agreed to divest its Habitrol line of nicotine patches.